Heparin-associated thrombocytopenia and thrombosis

Anesthesiology

Volumn 87, Issue 3, 1997, Pages 667-675

  Slaughter, Thomas F ^a   Greenberg, Charles S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Anticoagulation; Cardiac; Heparin induced; Surgery; Thrombocytopenia

Indexed keywords

HEPARIN DERIVATIVE;

ANTICOAGULATION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ARTIFICIAL EMBOLISM; DISEASE ASSOCIATION; HYPOTHESIS; INCIDENCE; MORBIDITY; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

ANTIBODIES; ANTICOAGULANTS; HEPARIN; HUMANS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0030764112     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199709000-00029     Document Type: Article

References (93)

1. McLean J: The thromboplastic action of cephalin. Am J Physiol 1916; 41:250-7
2. Weismann RE, Tobin RW: Arterial embolism occurriug during systemic heparin therapy. Arch Surg 1958; 76:219-27
3. Best CH: Preparation of heparin and its use in the first clinical cases. Circulation 1959; 19:79-86
4. Copley AL, Robb TP: The effect of heparin on the platelet count in dogs and mice. Am J Physiol 1941; 133: P248
5. Gollub S, Ulin AW: Heparin-induced thrombocytopenia in man. J Lab Clin Med 1962; 59:430-5
6. Roberts B, Rosato FE, Rosato EF: Heparin - a cause of arterial emboli? Surgery 1964:55:803-8
7. Rhodes GR, Dixon RH, Silver D: Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet 1973; 136:409-16
8. Warkentin TE, Kelton JG: Heparin-induced thrombocytopenia. Annu Rev Med 1989; 40:31-44
9. Kapsch D, Silver D: Heparin induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 1981; 116:1423-7
10. Phelan BK: Heparin-associaled thrombosis without thrombocytopenia. Ann Intern Med 1983; 99:637-8
11. Kappa JR, Fisher CA, Berkowitx HD, Cottrell ED, Addonizio VP Jr: Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management. J Vasc Surg 1987; 5:101-9
12. Green D: Heparin-induced thrombocytopenia (heparin supplement). Med J Aust 1986; 144:37-9
13. Chong BH: Heparin-induced thrombocytopenia. Aust N Z J Meet 1992; 22:145-52
14. Salzman EW, Rosenbcrg RD, Smith MH, Lindon JN, Favreau L: Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980; 65:64-73
15. Brace LD, Farced J: An objective assessment of the interaction of heparin and its fractions with human platelets. Semin Thromb Hemost 1985; 11:190-8
16. Baird RA, Convery FR: Arterial thromboembolism in patients receiving systemic heparin therapy. A complication associated with heparin-indticed thrombocytopenia. J Bone Joint Surg 1977; 59A:1061-4
17. Becker PS, Miller VT: Heparin-induced thrombocytopenia. Stroke 1989; 20:1449-59
18. Ramirez-Lassepas M, Cipolle RJ. Rodvold KA, Seifert RD, Strand L, Taddeini L, Cusulos M: Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease. Neurology 1984; 34:736-40
19. Cummings JM, Mason TJ, Chomka EV, Pouget JM: Fibrinolytic therapy of acute myocardial infarction in the heparin thrombosis syndrome. Am Heart J 1986; 112:407-9
20. Van Der Weyden MB, Hunt H, McGrath K, Fawcett T, Fitzmaurice A, Sawers RJ, Rosengarten DS: Delayed-onset heparin-induced thrombocytopenia. A potentially malignant syndrome. Med J Aust 1983; 2:132-5
21. White PW, Sadd JR, Nensel RE: Thrombotic complications of heparin therapy. Including six cases of heparin-induced skin necrosis. Ann Surg 1979; 190:595-608
22. Hartman AR, Hood RM, Anagnostopoulos CE: Phenomenon of heparin-induced thrombocytopenia associated with skin necrosis. J Vasc Surg 1988; 7:781-4
23. Arthur CK, Isbister JP, Aspery EM: The heparin induced thromliosis-thrombocytopenia syndrome (H.I.T.T.S.): A review. Pathology 1985; 17:82-6
24. Arthur CK, Grant SJB, Murray WK, Isbister JP, Stiel JN, Lauer CS: Heparin-associated acute adrenal insufficiency. Aust N Z J Med 1985; 15:454-5
25. Findling JW, Korducki JM, Lahiri PK, Miller DD. Raff H: Bilateral adrenal hemorrhage associated with heparin-indueed thrombocytopenia. Wisc Med J 1987; 86:27-9
26. Battey PM, Salam AA: Venous gangrene associated with heparin-induced thrombocytopenia. Surgery 1985; 97:618-20
27. Blanke H, Lesch M, Strauer BE: Heparin-induced thrombocytopenia. Deutsche Medicinische Wochenschrift 1987; 12:96-9
28. Silver D, Kapsch DN, Tsoi EK: Heparin associated thrombocytopenia, thrombosis and hemorrhage. Ann Surg 1983; 198:301-6
29. Kelton JG: Heparin-induced thrombocytopenia Haemostasis 1986; 16:173-86
30. Towne JB, Bernhard VM, Hussey C Garancis JC: White clot syndrome: peripheral vascular complications of heparin therapy. Arch Surg 1979; 114:372-7
31. Ansell J, Deykin D: Heparin-induced thrombocytopenia and recurrent thromboembolism. Am J Hematol 1980; 8:325-32
32. Eika G, Godal HC, Laake K, Hamburg T: Low incidence of thrombocytopenia during treatment with hog mucosa and beef lung heparin. Scand J Haematol 1980; 25:19-24
33. Bell WR, Tomasulo PA, Alving BM, Duffy TP: Thrombocytopenia occurring during the administration of heparin. Ann Intern Med 1976; 85:155-60
34. Bell WR, Royall RM: Heparin-associated thrombocytopenia: A comparison of three hcparin preparations. N Engl J Med 1980; 303:902-7
35. Powers PJ, Kelton JG, Carter CJ: Studies on the frequency of heparin-associated thrombocytopenia. Thromb Res 1984; 33:439-43
36. Schmitt BP, Adelman B: Heparin-associated thrombocytopenia: A critical review and a pooled analysis. Am J Med Sci 1993; 305:208-15
37. Johnson RA, Lazarus KH, Henry DH: Heparin-induced thrombocytopenia: A prospective study. Am J Hemat 1984; 17:349-53
38. Hrushesky WJ: Subcutaneous heparin-induced thrombocytopenia. Arch Intern Med 1978; 138:1489-91
39. Galle PC, Muss HB, McGrath K, Stuart JJ. Homesley HD: Thrombocytpenia in two patients treated with low-dose heparin. Obstet Gynecol 1978; 52(Suppl 1):9S-11S
40. Heeger PS, Backstrom JT: Heparin flushes and thrombocytopenia. Ann Intern Med 1986; 105:143
41. Laster J, Silver DS: Heparin-coated catheters and heparin-induced thrombocytopenia. J Vasc Surg 1988; 7:667-72
42. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332:1330-5
43. Horellou MH, Conard J, Lecrubier C, Samama M, Roque-D'Orbcastel O, de Fenoyl O, Di Maria G, Bernadou A: Persistent heparin induced thrombocytopenta despite therapy with low-molecularweight heparin. Thromli Haemost 1984; 51:134
44. Leroy J, Leclerc MH, Delahousse B, Guerois C, Feloppe P, Gruel Y, Toulemonde F: Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY216). Semin Thromb Hemost 1985; 11:326-9
45. Chong BH, Pitney WR, Castaldi PA: Heparin-irtdneed thrombocytopenia; association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 1982; 2:1246-9
46. Frame JN, Mulvey KP, Phares JC, Anderson MJ: Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin. Ann Intern Med 1989; 111:946-7
47. Chong BH: Heparin-indueed thrombocytopenia. Br J Haematol 1995; 89:431-9
48. Kelton JG, Sheridan D, Santos A, Smith J, Sleeves K, Smith C, Brown C, Murphy WG: Heparin-induced thrombocytopenia: Laboratory studies. Blood 1988; 72:925-30
49. Chong BH, Ismail F: The mechanism of heparin-induced platelet aggregation. Eur J Haematol 1989; 43:245-51
50. Amiral J. Bridey F, Dreyfus M, Vissac AM, Fressinatid E, Wolf M, Meycr D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68:95-6
51. Gruel Y, Boizard-Boval B, Wautier JL: Further evidence that alpha-granule components such as platelet factor 4 are involved in platelet-IgG-heparin interactions during heparin-associated thrombocytopenia. Thromb Haemost 1993; 70:374-5
52. Warkentin TE, Kelton JG: Heparin and platelets. Hemat Oncol Clin North Am 1990; 4:243-64
53. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt CM: Heparin-associated thrombocytopenia: Isolation of (he antibody and characterization of a multimolecular PF4heparin complex as the major antigen. Thromb Haemost 1994; 71:247-51
54. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced throtnbocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93:81-8
55. Warkentin TK, Hayward CPM, Boshkov LK, Santos AV, Sheppard JI, Bode AP, Kelton JG: Sera from patients with heparin-induced thronibocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 11:3691-9
56. Bode AP, Sandberg H, Dombrose FA, Lentz BR: Association of factor V activity with membranous vesicles released from human platelets: Requirement for platelet stimulation, Thromb Res 1985; 39:49-61
57. Barzu T, Van Rijn JLML, Petitou M, Molho P, Tobelem G, Caen JP: Endothelial binding sites for heparin, Biochem J 1986; 238:847-54
58. Cines DB, Tomaski A, Tannenbaum S: Immune endothelial-cell injury in heparin-associated thrombocylopenia. N Engl J Med 1987; 316:581-9
59. Makhoul RG, Greenberg CS, McCann RL: Heparin-associated thrombocytopenia and thrombosis: A serious clinical problem and potential solution. J Vase Surg 1986; 4:522-8
60. Laster J, Elfrink R, Silver D: Reexposure to heparin of patients with heparin-associated antibodies, J Vasc Surg 1989; 9:677-82
61. Walls JT, Curtis JJ, Silver D: Heparin-indueed thrombocytopenia in patients who undergo open heart surgery. Surgery 1990; 108:686-93
62. Walls JT, Curtis JJ, Silver D, Boley TM, Schmaltz RA, Nawarawong W: Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognition. Ann Thorac Surg 1992; 53:787-91
63. Bauer TL, Arepalli G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncx M, McNulty S, Edie RN, Mannion JD: Heparin-indueed antibody formation and platelet activation in patients undergoing cardiopulmonary bypass surgery. Blood 1995; 86(Suppl l):550a
64. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparininduced thrombocytopenia. Blood 1986; 67:27-30
65. Chong BH, Castaldi PA: Heparin-induced thrombocytopenia. Blut 1989; 58:53-7
66. Kelton JG, Sheridan D, Brain H, Powers PJ, Turpie AG, Carter CJ: Clinical usefulness of testing for a heparin-dependent plateletaggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 1984; 103:606-12
67. Chong BH, Burgess J, Ismail F: The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993; 69:344-50
68. Stewart MW, Etches WS, Boshkov LK, Gordon PA: Heparin- induced thrombocytopenia: An improved method of detection based on lumi- aggregometry. Br J Haematol 1995; 91:173-7
69. Amiral J, Bridey F, Wolf M, Boyer-Neuman C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meycr D: Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases. Thromb Haemost 1995; 73:21-8
70. Lasier J, Cikrit D, Walker N, Silver D: The heparin-induccd thrombocytopenia syndrome: An update. Surgery 1987; 102:763-70
71. Sobel M, Adelman B, Szentpetery S. Hoffman M, Posner MP, Jenvey W: Surgical management of heparin-associated thrombocytopenia. J Vasc Surg 1988; 8:395-401
72. Stiekema JCJ, Wijnand HP, van Dinther THG, Moelker HCT, Dawes J. Vinchenzo A, Toeberich H: Safety and pharmokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers. Br J Clin Pharmacol 1989; 27:39-48
73. Ortel TL, Gockerman JP, Califf RM: Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis. Thromb Haemost 1992; 67:292-6
74. Magnani HN: Heparin-induced thrombocylopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 1993; 70:554-61
75. Olinger GN, Hussey CV, Olive JA. Malik MI: Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation. J Thorac Cardiovasc Surg 1984; 87:673-7
76. Kapsch DN, Adelstein EH, Rhodes GR, Silver D: Heparin-induced thrombocytopenia, thrombosis, and hemorrhage. Surgery 1979; 86:148-55
77. Nand S, Robinson JA: Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis. Am J Hematol 1988; 28:204-6
78. Brady J, Riccio JA, Yumen OH, Makary AZ, Greenwood SM: Plasmapheresis: A therapeutic option in the management of heparinassociated thrombocytopenia with thrombosis. Am J Clin Pathol 1991; 96:394-7
79. Sloand EM, Pitt E, Klein HG: Safety of the blood supply. JAMA 1995; 274:1368-73
80. Kappa JR, Fisher CA, Todd B Stenach N, Bell P, Campbell F, Ellison N, Addonizio VP: Intraoperative management of patients with heparin-induced thrombocytopenia. Ann Thorac Surg 1990; 49:714-723
81. Addonixio VP, Fisher CA, Kappa JR, Ellison N: Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374). Surgery 1987; 102:796-807
82. Corbeau JJ, Jacob JP, Moreau X, Cottineau C, De Brux JL, Delhumeau A: Iloprost and extracorporeal circulation with conventional heparinization in a patient with heparin-induced thrombocyto penia. Annales Francais d'Anethesie et de Reanimation 1993; 12:559
83. Chong Bit, Ismail F, Cade J, Ciallius AS, Gordon S, Chesterman CN: Heparin induced thrombocytopenia: Studies with a new low molecular weight heparinoid. Org 10172. Blood 1989; 73:1592-6
84. Doherty DC, Ortel TL, DeBruijn N, Greenberg CS, Van Tright III P: "Heparin-free" cardiopulmonan" bypass: First reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass. ANESTHESIOLOGY 1990; 73:562-5
85. Cole CW, Fournier LM, Bormanis J: Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod. Can J Surg 1990; 33:207-10
86. Demers C, Ginsberg JS, Brill-Edwards P, Panju A, Warkentin T, Anderson DR: Rapid anticoagulation using ancrod in heparin induced thrombocytopenia. Blood 1991; 78:2194-7
87. Zulys VJ, Teasdale SJ, Michel ER, Skala RA, Keating SE, Viger JR, Glynn MFX: Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. ANESTHESIOLOGY 1989; 71:870-7
88. Teasdale SJ, Zulys VJ, Mycyk T, Baird RJ, Glynn MFX: Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis. Ann Thorac Surg 1989; 48:712-3
89. Spiekermann BF, Lake CL, Rich GF, Humphries JE: Normal activated clotting time despite anticoagulation with ancrod in a patient with heparin-associated thrombocytopeoia and thrombosis undergoing cardiopulmonary bypass. ANESTHESIOLOGY 1994; 80:686-8
90. O-Yurvati Ah, Laub GW, Southgate TJ, McGrath LB: Heparinless cardiopulmonary bypass with ancrod. Ann Thorac Surg 1994; 57:1656-8
91. Nand S: Hirudin therapy for heparin-associated thrombocyto- penia and deep venous thrombosis. Am J Hematol 1993; 43:310-1
92. Riess FC, Lower C, Seelig C, Bleese N, Kormann J, MullerBerghaus G, Potzsch B: Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in man. J Thorac Cardiovasc Surg 1995; 110:265-
93. Matsuo T, Kario K, Chikahira Y, Nakao K, Yamada T: Treatment of heparin-induced thrombocytopenia by use of argalroban, a synthetic thrombin inhibitor. Br j Haematol 1992; 82:627-9